HCV-TARGET Team

HCV-TARGET Team

Led jointly by the University of Florida and the University of North Carolina at Chapel Hill, HCV-TARGET is an international research consortium created to inform the ongoing transformation of hepatitis C treatment and research.   Steering Committee Michael...

Hypothesis

A carefully maintained longitudinal, observational study of patients treated with telaprevir and boceprevir within academic and real-world community practices can rapidly inform strategies: For better management of populations both represented and underrepresented in...
HCV-TARGET and the CTSA

HCV-TARGET and the CTSA

The HCV-TARGET model is rooted in the infrastructure and collaborative network developed through the National Institutes of Health’s Clinical and Translational Science Award (CTSA) program, which is led by the NIH’s National Center for Advancing Translational...